Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial.

Dermatology and therapy·2026
Same author

Correction: Oregon primary care providers as a frontline defense in the War on Melanoma™: improving access to melanoma education.

Frontiers in medicine·2026
Same author

Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis.

JCI insight·2025
Same author

Implementation and Impact of a Dermoscopy-Enabled Dermatology eConsult Application in Primary Care.

Journal of primary care & community health·2025
Same author

Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks.

American journal of clinical dermatology·2025
Same author

Prospective evaluation of an AI-enabled elastic scattering spectroscopy device for triage of patient-identified skin lesions in dermatology clinics.

JAAD international·2025

Related Experiment Video

Updated: Jun 29, 2026

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
09:37

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition

Published on: August 18, 2022

DERM-SUCCESS FDA Pivotal Study: A Multi-Reader Multi-Case Evaluation of Primary Care Physicians' Skin Cancer

Laura K Ferris1, Erik Jaklitsch2, Elizabeth V Seiverling2,3

  • 1Department of Dermatology, University of North Carolina, Chapel Hill, USA.

Journal of Primary Care & Community Health
|May 31, 2025
PubMed
Summary

A new Elastic Scattering Spectroscopy (ESS) device significantly improved primary care physicians' (PCPs) ability to detect skin cancer, enhancing diagnostic sensitivity and management confidence. This AI-powered tool aids in evaluating suspicious lesions without biopsies.

Keywords:
artificial intelligencebasal cell carcinomadiagnostic toolselastic scattering spectroscopymachine learningmelanomaskin cancersquamous cell carcinomatechnology

More Related Videos

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

Related Experiment Videos

Last Updated: Jun 29, 2026

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
09:37

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition

Published on: August 18, 2022

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

Area of Science:

  • Optical diagnostics
  • Dermatology
  • Artificial Intelligence in Medicine

Background:

  • Elastic Scattering Spectroscopy (ESS) is an optical technique for in vivo tissue analysis.
  • It differentiates benign from malignant tissues, potentially avoiding surgical biopsies.
  • An AI-enabled handheld ESS device was developed to assist primary care physicians (PCPs) in managing skin lesions suspicious for cancer.

Purpose of the Study:

  • To evaluate the impact of an AI-assisted ESS device on PCP diagnostic and management performance for skin cancer detection.
  • To compare PCP performance with and without the ESS device's objective output.

Main Methods:

  • A clinical utility study involving 108 PCPs evaluating 100 skin lesion cases.
  • Cases were divided into two groups: 50 aided by ESS device output and 50 unaided.
  • PCPs provided diagnosis, management decisions, and confidence levels, both before and after device use.

Main Results:

  • Device-assisted evaluation significantly increased diagnostic sensitivity (71.1% to 81.7%) and referral sensitivity (82.0% to 91.4%).
  • Overall management performance (AUC) improved from 0.708 to 0.762 with device use.
  • Physician confidence in management decisions increased significantly, particularly for initially uncertain cases.

Conclusions:

  • The AI-powered ESS device significantly enhances PCPs' diagnostic and management sensitivities for skin cancer detection.
  • The device improves overall management performance and physician confidence in evaluating skin lesions.
  • ESS technology shows promise as an objective tool to aid PCPs in skin cancer management.